GM1 Ganglioside in Parkinson’s Disease: Pilot Study of Effects on Dopamine Transporter Binding

OBJECTIVE: GM1 ganglioside has been suggested as a treatment for Parkinson’s disease (PD), potentially having symptomatic and disease modifying effects. The current pilot imaging study was performed to examine effects of GM1 on dopamine transporter binding, as a surrogate measure of disease progress...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurol Sci
Autors principals: Schneider, Jay S., Cambi, Franca, Gollomp, Stephen M., Kuwabara, Hiroto, Brašić, James R., Leiby, Benjamin, Sendek, Stephanie, Wong, Dean F.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4545312/
https://ncbi.nlm.nih.gov/pubmed/26099170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2015.06.028
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars